Key facts
- This page summarizes Paul A. Grayson's Form 4 filing for Skye Bioscience, Inc. (SKYE).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 02 Apr 2026, 18:15.
Paul A. Grayson - 31 Mar 2026 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)
- Reporting relationship
- Director
- Issuer ticker
- SKYE
- Reported as of
- 31 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Apr 2026, 18:15:15 UTC
- Prior SEC filing
- 09 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Punit S. Dhillon, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Paul A. Grayson filed Form 4 for Skye Bioscience, Inc. (SKYE) on 02 Apr 2026.
Change
- Previous filing in this sequence was filed on 09 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001861554
Primary reporting owner
Grayson Paul A.
- Relationship
- Director
- Address
- C/O SKYE BIOSCIENCE, INC., 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
- Signature
- /s/ Punit S. Dhillon, as Attorney-in-Fact
- Signature date
- 02 Apr 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SKYE
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +75,000
- Change %
- Price
- $0.000000*
- Shares after
- 75,000
- Date
- 31 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $0.6150
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock option vests in equal monthly installments over the one year period beginning March 31, 2026.